Item

Bilberry Juice Powder (VM125)

We undertake to inform customers in the event of any change to this information.
Botanicals
Applications
  • Beverages
  • Fruits & Vegetables
  • Functional Food and Nutrition
  • Functional Beverages
  • Dietary Supplements/Nutraceuticals
Functions
  • Antioxidant
  • Flavor
  • Active Ingredient
  • Immune Health
  • Sports Nutrition
Features & benefits
  • Plant-based
  • Vegetarian
  • Conventional
Tags
  • Coloring
  • Flavor
  • Juice Powder
Locations
Location name Address
Huisong Pharmaceuticals 236 N. Jianguo Road 15F Hangzhou, ZJ 310003 CHN
U.S. Branch Office 1211 E. Dyer Rd STE 100 Santa Ana, CA 92705
Documents
Type Location File name Effective Expiration
HACCP Huisong Pharmaceuticals 14. ZLT7-01-6 HACCP Plan-Powder_EN.pdf 4/8/2025 4/7/2028
Allergens U.S. Branch Office Allergens.pdf 11/7/2024 11/7/2026
Allergens Huisong Pharmaceuticals Allergens.pdf 4/9/2025 4/9/2027
CoA Sample U.S. Branch Office COA VM125-240401 Bilberry Juice Powder.pdf 4/1/2024 4/1/2026
Country of Origin U.S. Branch Office Country of Origin.pdf 11/6/2024 11/6/2027
Product Specification Sheet U.S. Branch Office ESVM125-00U01 Bilberry Juice Powder.pdf 11/6/2024 11/6/2027
Gluten Huisong Pharmaceuticals GFSVM125-01U01 Gluten Free Statement.pdf 4/8/2025 4/8/2027
Heavy Metal Huisong Pharmaceuticals HMSVM125-01U01 Heavy Metals Statement.pdf 4/8/2025 4/8/2027
HACCP Process Flow Diagram Huisong Pharmaceuticals MFCVM125-01U02 Bilberry Juice Powder for Sam W00670.pdf 4/16/2025 4/16/2027
Safety Data Sheet (SDS) U.S. Branch Office MSDSVM125-01U01 Material Safety Data Sheet-Bilberry Juice Powder.pdf 11/6/2024 11/6/2027
Melamine Huisong Pharmaceuticals MSVM125-01U01 Melamine Statement.pdf 4/8/2025 4/8/2026
Organic Huisong Pharmaceuticals NotApplicable_Organic.pdf 4/9/2025 4/9/2027
Residual Statement Huisong Pharmaceuticals NotApplicable_ResidualStatement.pdf 4/9/2025 4/9/2026
Nutrition U.S. Branch Office Nutrition.pdf 11/6/2024 11/6/2027
Nutrition Huisong Pharmaceuticals Nutrition.pdf 4/11/2025 4/10/2028
GRAS/NDI/ODI Statement Huisong Pharmaceuticals ODIVM125-01U01 ODI Statement.pdf 4/8/2025 4/7/2028
Huisong Pharmaceuticals